Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
NCT05707910
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Malignant Tumor
Interventions
BIOLOGICAL:
EBV immunological agent
Sponsor
West China Hospital